Piramal Pharma deploying $85 mn capex this fiscal: Nandini Piramal

Quick Summary:

Piramal Pharma is utilising a capex of about USD 85 million for various initiatives, including capacity expansion, maintenance and de-bottlenecking of CDMO sites, in the current fiscal, according to its Chairperson Nandini Piramal.

"We expect the capex this year to be at a similar level as last year, which is about USD 85 million," Piramal told PTI in an interaction.

The Mumbai-headquartered firm, which aims to cross USD 2 billion in revenue by FY30, has already invested around USD 30 million in the first half of the ongoing fiscal on the initiatives.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: India

Topics: Chairperson Piramal Group Nandini Piramal Pharmaceuticals (NEC) Consumer healthcare Ajay Piramal Kentucky Piramal Pharma Manufacturing Mumbai United States Piramal Pharma Solutions Piramal Over-the-counter products Gujarat Lexington Contract Development and Manufacturing Organisation Contract manufacturing organization

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-10-27 @ 12:11:25 (1 days ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 413 words

Reading Time: 3 minutes read

Sentences: 14 lines

Sentence Length: 30 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 23259373

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 335 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions